Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Advanced Biomed Inc. ( (ADVB) ) has provided an announcement.
On December 23, 2025, Advanced Biomed Inc. agreed to spin off its wholly owned Hong Kong subsidiary, Advanced Biomed (HK) Limited, by selling 100% of its shares to an unrelated buyer, Wei Ha Hui, for US$23,000. On January 26, 2026, the company executed a Supplemental Agreement under which Advanced Biomed (HK) Limited formally acknowledged indebtedness of US$6,925,549 to the parent company, representing its accounts receivable, and irrevocably committed to repay this amount in full within one year of the Supplemental Agreement’s date. The amendment, unanimously approved by Advanced Biomed’s board, clarifies the repayment obligation as part of the spin-off, underscoring the company’s effort to recover substantial intercompany receivables while finalizing the divestiture of the Hong Kong subsidiary.
More about Advanced Biomed Inc.
Advanced Biomed Inc. operates through subsidiaries including Advanced Biomed (HK) Limited, reflecting a corporate structure with international operations and intercompany financing arrangements, though the specific industry and primary products or services are not disclosed in the release.
Average Trading Volume: 1,055,604
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.69M
See more data about ADVB stock on TipRanks’ Stock Analysis page.